Science for Life.
ProPhase Labs develops and markets clinically proven remedies including the highly effective Cold-EEZE® and Kids-EEZE® product lines. Our ongoing objective is to deliver long-term value by providing exceptional new products that address the health care and quality of life concerns of the broadest market segments.
September 10, 2014 - ProPhase Expects to Report a $3.6 Million Impairment Charge Relating to its Phusion Joint Venture
August 12, 2014 - ProPhase Labs Reports Financial Results for the Three and Six Months Ended June 30, 2014
May 12, 2014 - ProPhase Labs Reports Financial Results for the First Quarter Ended March 31, 2014
The Cold-EEZE® family of lozenges and sugar free tablets are clinically proven to significantly reduce the severity and duration of the common cold.